The National Health Insurance Bureau launched the medical insurance drug access negotiation this week
-
Last Update: 2019-11-11
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On November 11, reporters learned that the national health insurance bureau started a new round of negotiations on the access of Medicare drugs this week The health insurance bureau had previously planned to include 128 drugs in the negotiation, including 109 Western medicines and 19 Chinese patent medicines These drugs are mainly used in the treatment of cancer, rare diseases and other major diseases, hepatitis C, hepatitis B, hypertension, diabetes and other chronic diseases Many of these products are new drugs approved by the State Food and drug administration, including major innovative drugs in China.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
